The ALS/PDC syndrome of Guam and the cycad hypothesis
 

NEUROLOGY 2008;70:1984-1990
© 2008 American Academy of Neurology

--------------------------------------------------------------------------------
Views and Reviews

The ALS/PDC syndrome of Guam and the cycad hypothesis
John C. Steele, MD and Patrick L. McGeer, MD, PhD
From Guam Memorial Hospital (J.C.S.), Agana, Guam; and Kinsmen Laboratory of Neurological Research (P.L.M.), University of British Columbia, Vancouver BC, Canada.

Address correspondence and reprint requests to Dr. Patrick L. McGeer, Kinsmen Laboratory of Neurological Research, University of British Columbia, Vancouver, BC, Canada V6T1Z3 mcgeerpl@interchange.ubc.ca

There is a high incidence on Guam of a severe tauopathy known as the Parkinson- dementia complex (PDC). It is linked with an even more malignant amyotrophic lateral sclerosis (ALS) syndrome. There is great interest in determining the cause, or causes, of the Guam ALS/PDC syndrome because insight might be gained regarding ALS and the more common tauopathies found throughout the world. Research into the disorder is stimulated by hypotheses as to cause. Such hypotheses should be compatible with the known epidemiology and pathology of the syndrome. These include a high, if not exclusive, restriction to the Chamorro population, familial occurrence, a regional variation on Guam itself, a definite persistence but with declining incidence, and a possible duplication in isolated villages on the Kii peninsula of Japan. Proposed causation factors should also be able to reproduce the syndrome in experimental systems. This includes induction of neurofibrillary tangles with a tau isoform distribution similar to that of Alzheimer disease and association of the lesions with TDP-43 and Lrrk2. A recurring hypothesis as to causation is exposure to Cycas micronesica, the false Sago palm known locally as fadang. We review the reasons why this hypothesis falls short of the minimal criteria needed for further serious consideration and discuss some other possibilities that should not be excluded.

GLOSSARY: AD = Alzheimer disease; ALS = amyotrophic lateral sclerosis; FTLD-U = frontotemporal lobar degeneration with ubiquitinated inclusions; Lrrk2 = leucine-rich-repeat-kinase 2; MAPKKK = microtubule associated protein kinase kinase kinase; NFT = neurofibrillary tangle; PDC = Parkinson-dementia complex; PSP = progressive supranuclear palsy; SNPs = single nucleotide polymorphisms; TAR = transactive response; TDP-43 = TAR-DNA-binding protein 43.

http://www.neurology.org/cgi/content/short/70/21/1984